Advertisement
Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates
From: Acute canagliflozin treatment protects against in vivo myocardial ischemia–reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation
